The effects of ketamine and thiopental used alone or in combination on the brain, heart, and bronchial tissues of rats

ArticleAçık Erişim

Özet

Introduction: We compared the side effects of ketamine and thiopental used alone and of a ketamine/thiopental combination dose on the brain,heart, and bronchial tissues of rats. Material and methods: Three groups received intraperitoneal injections of 30 mg/kg ketamine (K-30); 15 mg/kg thiopental (T-15); or of both in combination (KTSA). These doses were doubled in another set of study groups (K-60, T-30, and KTA groups, respectively). Optimal anesthesia duration was examined in all groups. Results: Anesthesia did not occur with 30 mg/kg ketamine or 15 mg/kg thiopental. However, when used alone ketamine and thiopental led to oxidative stress in the striatum, heart, and bronchial tissues. Conversely, combined administration of anesthetics and subanesthetic doses were found not to create oxidative stress in any of these areas. The highest level of adrenaline in blood samples collected from the tail veins was measured in the KTA-60, and the lowest amount in the T-30. Creatine kinase activity was highest in the KTA-60 group (p < 0.001). When we compared for all 5 groups to untreated control group; the creatine kinase-MB activities were significiantly different in K-30, T-15 and T-30 (p < 0.001). Conclusions: The studied doses of ketamine led to oxidative stress by increasing the amount of adrenaline. Thiopental increased oxidative stress with decreases in adrenaline. A longer anesthetic effect with minimal adverse events may be achieved by ketamine and thiopental in combination. © 2016 Termedia & Banach.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/13974Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.5114/aoms.2016.59508Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAhiskalioglu, Elif Oral
dc.contributor.authorAydin, Pelin
dc.contributor.authorAhiskalioglu, Ali
dc.contributor.authorSuleyman, Bahadir
dc.contributor.authorKuyrukluyildiz, Ufuk
dc.contributor.authorKurt, Nezahat
dc.contributor.authorAltuner, Durdu
dc.contributor.authorCoskun, Resit
dc.contributor.authorSuleyman, Halis
dc.date.accessioned2026-10-18T20:28:46.600482522Z
dc.date.available2026-10-18T20:28:46.600482522Z
dc.date.issued2018
dc.description.abstractIntroduction: We compared the side effects of ketamine and thiopental used alone and of a ketamine/thiopental combination dose on the brain,heart, and bronchial tissues of rats. Material and methods: Three groups received intraperitoneal injections of 30 mg/kg ketamine (K-30); 15 mg/kg thiopental (T-15); or of both in combination (KTSA). These doses were doubled in another set of study groups (K-60, T-30, and KTA groups, respectively). Optimal anesthesia duration was examined in all groups. Results: Anesthesia did not occur with 30 mg/kg ketamine or 15 mg/kg thiopental. However, when used alone ketamine and thiopental led to oxidative stress in the striatum, heart, and bronchial tissues. Conversely, combined administration of anesthetics and subanesthetic doses were found not to create oxidative stress in any of these areas. The highest level of adrenaline in blood samples collected from the tail veins was measured in the KTA-60, and the lowest amount in the T-30. Creatine kinase activity was highest in the KTA-60 group (p < 0.001). When we compared for all 5 groups to untreated control group; the creatine kinase-MB activities were significiantly different in K-30, T-15 and T-30 (p < 0.001). Conclusions: The studied doses of ketamine led to oxidative stress by increasing the amount of adrenaline. Thiopental increased oxidative stress with decreases in adrenaline. A longer anesthetic effect with minimal adverse events may be achieved by ketamine and thiopental in combination. © 2016 Termedia & Banach.
dc.identifier.doi10.5114/aoms.2016.59508
dc.identifier.eissn1896-9151
dc.identifier.endpage654
dc.identifier.issn1734-1922
dc.identifier.issue3
dc.identifier.pmcidPMC5949904
dc.identifier.pmid29765454
dc.identifier.scopus2-s2.0-85045855000
dc.identifier.startpage645
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/13974
dc.identifier.volume14
dc.identifier.wosWOS:000433030200024
dc.language.isoen
dc.publisherTermedia Publishing House Ltd.
dc.relation.ispartofArchives of Medical Science
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCardiotoxicity
dc.subjectKetamine
dc.subjectNeurotoxicity
dc.subjectOxidative stress
dc.subjectThiopental
dc.subjectcreatine kinase
dc.subjectepinephrine
dc.subjectanimal experiment
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectbrain tissue
dc.subjectbronchus tissue
dc.subjectcontrolled study
dc.subjectcorpus striatum
dc.subjectdrug brain level
dc.subjectdrug determination
dc.subjectdrug effect
dc.subjectdrug safety
dc.subjectenzyme activity
dc.subjectheart tissue
dc.subjectmale
dc.subjectnonhuman
dc.subjectnoradrenalin blood level
dc.subjectrat
dc.titleThe effects of ketamine and thiopental used alone or in combination on the brain, heart, and bronchial tissues of rats
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus29
rdl.citation.wos24
rdl.departmentDepartment of Pharmacology, Faculty of Medicine, Erzincan University, Erzincan, Turkey. | Department of Anesthesiology and Reanimation, Faculty of Medicine, Erzincan University, Erzincan, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)